Emerging markets witness slowdown in growth, HSBC report says

Emerging markets see growth slow down in February

Emerging markets see growth slow down in February

According to the newest report by HSBC, emerging markets saw their growth decelerate in February. The EMI showed that especially larger economies witnessed more sluggish economic growth.

EMI for February

On the 6th of March, HSBC released its Emerging Markets Index (EMI), showing that this indicator, which is collected from the PMI surveys, sharply slumped to 52.3 in February from 53.8 in January.  To crown it all, it has been the lowest result since August 2012. Certainly, the February’s HSBC EMI, which was based on purchasing managers’ surveys of 16 emerging economies, illustrated a moderation in economic growth in developing countries. However, the HSBC Emerging Markets Index (EMI) still was above the significant 50 level which means economic expansion.

According to the survey published by HSBC, the economic slowdown was significantly evident in India, Brazil and China which witnessed noticeable declines in their growth rates after strong results recorded in January. In addition, the slowdown was much visible in manufacturing and services sectors. Emerging markets undeniably continued to expand in February, but significantly slower. What is more, the February’s HSBC EMI showed that the BRIC economies (Brazil, Russia, India and China) saw new orders drop in the month. The economies noticed this decrease especially in the critical manufacturing sector. Data showed that new orders rate was the lowest in six months.

Without a doubt, investors are closely watching recent data on emerging markets as they are deeply interested in whether developing countries will continue to expand despite visibly strong obstacles on the economic recovery road. In particular, China is carefully observed as still investors and analysts are profoundly concerned over a possible slowdown in the world’s second largest economy.

Murat Ulgen, chief economist at HSBC, underlined:”The slowdown appears to be broad-based across manufacturing and services, with BRIC activity moderating after a promising start to the new year,” adding that there were two possible scenarios for emerging markets. Either emerging markets will be taken down by the concerns over the developed world or this economic slowdown will turn out to be only temporarily and developing countries will enjoy strong growth in the new future. Murat Ulgen has however highlighted that the second scenario would be much more viable due to economies of China, the Middle East, Latin America and Eastern Europe as they are expected to demonstrate their strength.

EM to change the picture

Not surprisingly, emerging markets, including Asia and Latin America, are the main contributors to the global economy growth as developed economies, including the UK and the US, are still struggling with economic headwinds. To top it all, analysts are strongly convinced that emerging markets are hope for economic growth. According to some estimates, China and Vietnam are expected to see double-digit growth between 2013  and 2020. India, on the other hand, is believed to increase its exports from 2016.

Providing that emerging markets are growing at enormous speed, they are going to change the picture of the world in the not so far future. Emerging markets are set to expand their exports, they are ready and hungry for the success. This hunger is also visible as there is an increasing appetite for high-end products in developing countries. Companies see that and simply want to invest. The rapid industrialization of emerging markets might be beneficial for developed economies, but they will have to know how to use it. Emerging markets will arguable change and reshape the world.

Anna Domanska
Anna Domanska is an Industry Leaders Magazine author possessing wide-range of knowledge for Business News. She is an avid reader and writer of Business and CEO Magazines and a rigorous follower of Business Leaders.

Recent Posts

Bayer snaps up biotech firm Vividion Therapeutics for $2 billion

Bayer snaps up biotech firm Vividion Therapeutics for $2 billion

Bayer AG is in talks to buy Vividion Therapeutics in a roughly $2 billion deal, enforcing new IPO plans for Vividion.
3 hours ago
Auto Industry Leaders push EV plans to maintain leadership

Auto Industry Leaders push EV plans to maintain leadership

Auto Industry Leaders push EV plans ahead to raise new outcomes by 2030. Environmentalists also add to the bar by shaking things with vehicle emission rules by 2026.
6 hours ago
General Motors Q2 2021 Results Recap

General Motors Q2 2021 Results Recap

General Motors Q2 earnings and revenue missed Wall Street’s expectations even though the world’s leading automaker beat earnings projections.
1 day ago
UK casts doubt over Nvidia’s Arm acquisition over security risks

UK casts doubt over Nvidia’s Arm acquisition over security risks

UK considers blocking Nvidia’s Arm acquisition due to potential risks to national security. The $40 billion takeover faces similar fate in America, China and the European Union.
1 day ago
PepsiCo relinquishes control of Tropicana for $3.3 billion

PepsiCo relinquishes control of Tropicana for $3.3 billion

PepsiCo will sell Tropicana and other juice brands to a private equity firm in exchange for pre-tax proceeds of 3.3 billion dollars.
2 days ago
Sanofi bets big on mRNA future with Translate Bio acquisition offer

Sanofi bets big on mRNA future with Translate Bio acquisition offer

Sanofi’s CEO Paul Hudson is dead serious about mRNA technology and capabilities with a $3.2 billion acquisition offer to Translate Bio.
2 days ago